NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Informatica Inc. ("Informatica" or "the Company") (NYSE:INFA). Investors who purchased Informatica securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INFA. Investigation DetailsOn February 13, 2025, Informatica reported its Q4 2024 and ...
ACCESSWIRE
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Stitch Fix, Inc. ("Stitch Fix" or "the Company") (NASDAQ:SFIX). Investors who purchased Stitch Fix securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SFIX. Investigation DetailsOn September 24, 2025, Stitch Fix announced its Q4 and full-year ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Braskem S.A. ("Braskem" or "the Company") (NYSE:BAK). Investors who purchased Braskem securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BAK. Investigation DetailsOn September 26, 2025, Braskem announced that it had "retained financial ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MoonLake Immunotherapeutics ("MoonLake" or "the Company") (NASDAQ:MLTX). Investors who purchased MoonLake securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MLTX. Investigation DetailsOn September 28, 2025, MoonLake reported disappointing ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Larimar Therapeutics, Inc. ("Larimar" or "the Company") (NASDAQ:LRMR). Investors who purchased Larimar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LRMR. Investigation DetailsOn September 29, 2025, Larimar announced data from an ongoing ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Spirit Aviation Holdings, Inc. ("Spirit" or "the Company") (OTCMKTS: FLYYQ) and certain of its officers. Class DefinitionThis lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jefferies Financial Group Inc. ("Jefferies" or "the Company") (NYSE:JEF). Investors who purchased Jefferies securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/JEF. Investigation DetailsOn October 8, 2025, Jefferies admitted that it had about ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of American Battery Technology Company ("American Battery" or "the Company") (NASDAQ:ABAT). Investors who purchased American Battery securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ABAT. Investigation DetailsOn October 15, 2025, American ...
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Protalix BioTherapeutics, Inc. ("Protalix" or "the Company") (NYSE:PLX). Investors who purchased Protalix securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PLX. Investigation DetailsOn October 17, 2025, Protalix and Chiesi Global Rare ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Palantir Technologies Inc. ("Palantir Technologies Inc.") (NASDAQ:PLTR) concerning possible violations of federal securities laws.Media outlets reported on October 3, 2025, that an internal U.S. Army memo described the NGC2 platform - a battlefield communication system developed by Palantir and Anduril Industries - as a "very high risk" due ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.THE LAWSUIT: ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of United Homes Group, Inc. ("United Homes Group, Inc.") (NASDAQ:UHG) concerning possible violations of federal securities laws.On October 20, 2025, six UHG board members resigned following the refusal of Executive Chairman Michael Nieri to step down from his role at the Company and forgo any future compensation. Nieri's refusal to agree to those ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ:MLTX) concerning possible violations of federal securities laws.On September 29, 2025, MoonLake announced that its experimental immune disease drug sonelokimab for the treatment of a chronic inflammatory skin condition, hidradenitis suppurativa, failed to meet that one of its late-stage trials.
NEW YORK, NY / ACCESS Newswire / October 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of United Homes Group, Inc. ("United Homes Group, Inc.") (NASDAQ:UHG) concerning possible violations of federal securities laws.On October 20, 2025, six UHG board members resigned following the refusal of Executive Chairman Michael Nieri to step down from his role at the Company and forgo any future compensation. Nieri's refusal to agree to those ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your Dow Inc. (NYSE:DOW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.THE ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of ...
NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tandem Diabetes Care, Inc. ("Tandem Diabetes Care, Inc.") (NASDAQ:TNDM) concerning possible violations of federal securities laws.Tandem disclosed on August 7, 2025, that a malfunction had been identified in some of its insulin pumps, which could "trigger an error resulting in a discontinuation of insulin delivery," which "could result ...